Literature DB >> 4507808

Specific noradrenergic neurones destroyed by 6-hydroxydopamine injection into newborn rats.

K M Taylor, D W Clark, R Laverty, E L Phelan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4507808     DOI: 10.1038/newbio239247a0

Source DB:  PubMed          Journal:  Nat New Biol        ISSN: 0090-0028


× No keyword cloud information.
  8 in total

1.  Effects of 6-hydroxydopamine Treatment at birth on the submaxillary gland of the rat.

Authors:  C J Perec; F J Stefano; C M Baratti; O R Tumilasci
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

2.  5-HT agonist induced analgesia modulated by central but not peripheral noradrenaline depletion in rats.

Authors:  B G Minor; T Archer; C Post; G Jonsson; A K Mohammed
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

3.  Degeneration in the adult rat spinal cord following systemic treatment with 6-hydroxydopamine. Electron microscopic study.

Authors:  W C Wong; C K Tan
Journal:  Experientia       Date:  1974-12-15

4.  Operant behavioural and neurochemical effects after neonatal 6-hydroxydopamine treatment.

Authors:  D W Peterson; R Laverty
Journal:  Psychopharmacology (Berl)       Date:  1976-10-20       Impact factor: 4.530

5.  Clonidine-induced sedation in rats: evidence for mediation by postsynaptic alpha 2-adrenoreceptors.

Authors:  C Spyraki; H C Fibiger
Journal:  J Neural Transm       Date:  1982       Impact factor: 3.575

6.  Alcohol intake, ethanol-induced narcosis and intoxication in rats following neonatal 6-hydroxydopamine or 5, 7-dihydroxytryptamine treatment.

Authors:  K Kiianmaa; L M Attila
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-08       Impact factor: 3.000

7.  Noradrenergic involvement in dopamine-dependent stereotyped and cataleptic responses in the rat.

Authors:  C Pycock
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-05       Impact factor: 3.000

8.  Attenuation of heroin reward in rats by disruption of the mesolimbic dopamine system.

Authors:  C Spyraki; H C Fibiger; A G Phillips
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.